A. Dupuy

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

Risk factors for erysipelas of the leg (cellulitis): case-control study

A. Dupuy, H. Benchikhi, Jean‐Claude Roujeau et al. · BMJ · 1999 · 571 citations · Full text

Long-Term Management of Breast Cancer-Related Lymphedema after Intensive Decongestive Physiotherapy

S. Vignes, Raphaël Porcher, M. Arrault et al. · Breast Cancer Research and Treatment · 2006 · 171 citations

Breast Cancer, Surgery, Long-term Management +2

A three-year-analysis of fixed drug eruptions in hospital settings in France

N. Brahimi, Émilie Routier, Nadia Raison‐Peyron et al. · European Journal of Dermatology · 2010 · 149 citations

Pharmacotherapy, Dermatology, Skin Pigmentation +20

Treatment of Refractory Pemphigus Vulgaris With Rituximab (Anti-CD20 Monoclonal Antibody)

A. Dupuy, M. Viguier, Christophe Bédane et al. · Archives of Dermatology · 2004 · 141 citations